Lipid Nanoparticles for Nucleic Acid Delivery to Endothelial Cells

التفاصيل البيبلوغرافية
العنوان: Lipid Nanoparticles for Nucleic Acid Delivery to Endothelial Cells
المؤلفون: Gary W. Liu, Edward B. Guzman, Nandita Menon, Robert S. Langer
المصدر: Pharmaceutical Research. 40:3-25
بيانات النشر: Springer Science and Business Media LLC, 2023.
سنة النشر: 2023
مصطلحات موضوعية: Pharmacology, Organic Chemistry, Pharmaceutical Science, Molecular Medicine, Pharmacology (medical), Biotechnology
الوصف: Endothelial cells play critical roles in circulatory homeostasis and are also the gateway to the major organs of the body. Dysfunction, injury, and gene expression profiles of these cells can cause, or are caused by, prevalent chronic diseases such as diabetes, cardiovascular disease, and cancer. Modulation of gene expression within endothelial cells could therefore be therapeutically strategic in treating longstanding disease challenges. Lipid nanoparticles (LNP) have emerged as potent, scalable, and tunable carrier systems for delivering nucleic acids, making them attractive vehicles for gene delivery to endothelial cells. Here, we discuss the functions of endothelial cells and highlight some receptors that are upregulated during health and disease. Examples and applications of DNA, mRNA, circRNA, saRNA, siRNA, shRNA, miRNA, and ASO delivery to endothelial cells and their targets are reviewed, as well as LNP composition and morphology, formulation strategies, target proteins, and biomechanical factors that modulate endothelial cell targeting. Finally, we discuss FDA-approved LNPs as well as LNPs that have been tested in clinical trials and their challenges, and provide some perspectives as to how to surmount those challenges.
تدمد: 1573-904X
0724-8741
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::d6844aa2ac329b862ed5aad969fa5c9e
https://doi.org/10.1007/s11095-023-03471-7
حقوق: OPEN
رقم الأكسشن: edsair.doi...........d6844aa2ac329b862ed5aad969fa5c9e
قاعدة البيانات: OpenAIRE